vs

Side-by-side financial comparison of BWX Technologies, Inc. (BWXT) and CABOT CORP (CBT). Click either name above to swap in a different company.

BWX Technologies, Inc. is the larger business by last-quarter revenue ($860.2M vs $849.0M, roughly 1.0× CABOT CORP). BWX Technologies, Inc. runs the higher net margin — 10.6% vs 8.6%, a 2.0% gap on every dollar of revenue. On growth, BWX Technologies, Inc. posted the faster year-over-year revenue change (26.1% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $50.1M). Over the past eight quarters, BWX Technologies, Inc.'s revenue compounded faster (12.4% CAGR vs -8.7%).

BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

BWXT vs CBT — Head-to-Head

Bigger by revenue
BWXT
BWXT
1.0× larger
BWXT
$860.2M
$849.0M
CBT
Growing faster (revenue YoY)
BWXT
BWXT
+37.2% gap
BWXT
26.1%
-11.1%
CBT
Higher net margin
BWXT
BWXT
2.0% more per $
BWXT
10.6%
8.6%
CBT
More free cash flow
CBT
CBT
$6.9M more FCF
CBT
$57.0M
$50.1M
BWXT
Faster 2-yr revenue CAGR
BWXT
BWXT
Annualised
BWXT
12.4%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BWXT
BWXT
CBT
CBT
Revenue
$860.2M
$849.0M
Net Profit
$91.2M
$73.0M
Gross Margin
24.9%
Operating Margin
12.4%
15.2%
Net Margin
10.6%
8.6%
Revenue YoY
26.1%
-11.1%
Net Profit YoY
20.7%
-21.5%
EPS (diluted)
$0.99
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BWXT
BWXT
CBT
CBT
Q1 26
$860.2M
Q4 25
$885.8M
$849.0M
Q3 25
$866.3M
$899.0M
Q2 25
$764.0M
$923.0M
Q1 25
$682.3M
$936.0M
Q4 24
$746.3M
$955.0M
Q3 24
$672.0M
$1.0B
Q2 24
$681.5M
$1.0B
Net Profit
BWXT
BWXT
CBT
CBT
Q1 26
$91.2M
Q4 25
$93.0M
$73.0M
Q3 25
$82.1M
$43.0M
Q2 25
$78.4M
$101.0M
Q1 25
$75.5M
$94.0M
Q4 24
$71.0M
$93.0M
Q3 24
$69.5M
$137.0M
Q2 24
$73.0M
$109.0M
Gross Margin
BWXT
BWXT
CBT
CBT
Q1 26
Q4 25
24.9%
Q3 25
21.8%
24.5%
Q2 25
25.1%
26.4%
Q1 25
24.2%
25.7%
Q4 24
24.6%
Q3 24
24.4%
24.0%
Q2 24
24.7%
25.2%
Operating Margin
BWXT
BWXT
CBT
CBT
Q1 26
12.4%
Q4 25
10.4%
15.2%
Q3 25
13.1%
15.2%
Q2 25
13.4%
18.1%
Q1 25
14.2%
17.3%
Q4 24
12.4%
16.2%
Q3 24
14.4%
15.0%
Q2 24
14.5%
16.9%
Net Margin
BWXT
BWXT
CBT
CBT
Q1 26
10.6%
Q4 25
10.5%
8.6%
Q3 25
9.5%
4.8%
Q2 25
10.3%
10.9%
Q1 25
11.1%
10.0%
Q4 24
9.5%
9.7%
Q3 24
10.3%
13.7%
Q2 24
10.7%
10.7%
EPS (diluted)
BWXT
BWXT
CBT
CBT
Q1 26
$0.99
Q4 25
$1.02
$1.37
Q3 25
$0.89
$0.80
Q2 25
$0.85
$1.86
Q1 25
$0.82
$1.69
Q4 24
$0.77
$1.67
Q3 24
$0.76
$2.41
Q2 24
$0.79
$1.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BWXT
BWXT
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$512.4M
$230.0M
Total DebtLower is stronger
$2.0B
Stockholders' EquityBook value
$1.3B
$1.6B
Total Assets
$4.3B
$3.8B
Debt / EquityLower = less leverage
1.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BWXT
BWXT
CBT
CBT
Q1 26
$512.4M
Q4 25
$499.8M
$230.0M
Q3 25
$79.6M
$258.0M
Q2 25
$37.0M
$239.0M
Q1 25
$55.4M
$213.0M
Q4 24
$74.1M
$183.0M
Q3 24
$35.5M
$223.0M
Q2 24
$48.3M
$197.0M
Total Debt
BWXT
BWXT
CBT
CBT
Q1 26
$2.0B
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Stockholders' Equity
BWXT
BWXT
CBT
CBT
Q1 26
$1.3B
Q4 25
$1.2B
$1.6B
Q3 25
$1.2B
$1.6B
Q2 25
$1.2B
$1.5B
Q1 25
$1.1B
$1.4B
Q4 24
$1.1B
$1.4B
Q3 24
$1.1B
$1.4B
Q2 24
$998.5M
$1.3B
Total Assets
BWXT
BWXT
CBT
CBT
Q1 26
$4.3B
Q4 25
$4.3B
$3.8B
Q3 25
$3.8B
$3.8B
Q2 25
$3.7B
$3.8B
Q1 25
$3.1B
$3.8B
Q4 24
$2.9B
$3.6B
Q3 24
$2.9B
$3.7B
Q2 24
$2.8B
$3.6B
Debt / Equity
BWXT
BWXT
CBT
CBT
Q1 26
1.58×
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BWXT
BWXT
CBT
CBT
Operating Cash FlowLast quarter
$92.6M
$126.0M
Free Cash FlowOCF − Capex
$50.1M
$57.0M
FCF MarginFCF / Revenue
5.8%
6.7%
Capex IntensityCapex / Revenue
4.9%
8.1%
Cash ConversionOCF / Net Profit
1.02×
1.73×
TTM Free Cash FlowTrailing 4 quarters
$328.1M
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BWXT
BWXT
CBT
CBT
Q1 26
$92.6M
Q4 25
$127.0M
$126.0M
Q3 25
$143.2M
$219.0M
Q2 25
$159.0M
$249.0M
Q1 25
$50.6M
$73.0M
Q4 24
$276.9M
$124.0M
Q3 24
$32.6M
$204.0M
Q2 24
$65.9M
$207.0M
Free Cash Flow
BWXT
BWXT
CBT
CBT
Q1 26
$50.1M
Q4 25
$56.8M
$57.0M
Q3 25
$94.9M
$155.0M
Q2 25
$126.3M
$188.0M
Q1 25
$17.3M
$1.0M
Q4 24
$224.4M
$47.0M
Q3 24
$-7.7M
$112.0M
Q2 24
$35.5M
$155.0M
FCF Margin
BWXT
BWXT
CBT
CBT
Q1 26
5.8%
Q4 25
6.4%
6.7%
Q3 25
11.0%
17.2%
Q2 25
16.5%
20.4%
Q1 25
2.5%
0.1%
Q4 24
30.1%
4.9%
Q3 24
-1.1%
11.2%
Q2 24
5.2%
15.3%
Capex Intensity
BWXT
BWXT
CBT
CBT
Q1 26
4.9%
Q4 25
7.9%
8.1%
Q3 25
5.6%
7.1%
Q2 25
4.3%
6.6%
Q1 25
4.9%
7.7%
Q4 24
7.0%
8.1%
Q3 24
6.0%
9.2%
Q2 24
4.5%
5.1%
Cash Conversion
BWXT
BWXT
CBT
CBT
Q1 26
1.02×
Q4 25
1.37×
1.73×
Q3 25
1.74×
5.09×
Q2 25
2.03×
2.47×
Q1 25
0.67×
0.78×
Q4 24
3.90×
1.33×
Q3 24
0.47×
1.49×
Q2 24
0.90×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BWXT
BWXT

Segment breakdown not available.

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons